| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-31 | Cisplatin | prostate cancer | Sensitive | Low | 21368878 | |
| miR-3175 | Cisplatin | ovarian cancer | Resistant | High | 22614869 | |
| miR-3183 | Cisplatin | hepatocellular cancer | Sensitive | High | 23229111 | |
| miR-31 | Cisplatin | gastric cancer | Sensitive | High | 23525256 | |
| miR-3131 | Cisplatin | gastric cancer | Sensitive | High | 23525256 | |
| miR-3149 | Cisplatin | gastric cancer | Sensitive | High | 23525256 | |
| miR-3162 | Cisplatin | gastric cancer | Sensitive | High | 23525256 | |
| miR-31 | Cisplatin | non-small cell lung cancer | Resistant | Low | 24099915 | |
| miR-31 | Cisplatin | ovarian cancer | Resistant | High | 24659709 | |
| miR-31 | Cisplatin | esophageal adenocarcinoma | Sensitive | High | 25356050 | |
| miR-3135a | Cisplatin | ovarian cancer | Resistant | High | 25872328 | |
| miR-31 | Cisplatin | ovarian cancer | Resistant | High | 26043084 | |
| miR-3175 | Cisplatin | ovarian cancer | Resistant | High | 26043084 |